pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
STAT·19h ago·1 min read
save

New York study questions effectiveness of involuntary outpatient mental health treatment, urges more funding for voluntary services

Aug 4, 2026·read at STAT ↗Negative

A new evaluation of New York's involuntary outpatient treatment program adds to a growing body of research on court‑ordered mental health care. The study examined outcomes for people with serious conditions such as schizophrenia who are placed under assisted outpatient treatment (AOT).

The authors found that AOT was associated with reductions in hospitalizations and arrests, but noted that similar improvements were observed among patients receiving voluntary treatment. They highlighted concerns about coercion and potential harms experienced by individuals under AOT orders.

Based on the findings, the researchers recommended that the state direct additional resources toward voluntary services, arguing that engagement in care-whether voluntary or not-leads to better outcomes. The report calls for a reassessment of funding priorities in mental health programs.

source

This writeup was produced by pharmadog from original reporting by STAT.

Original headline: “STAT+: As Trump administration pushes court-ordered mental health care, a new report raises questions”

read at STAT ↗
492 words · retrieved 18h ago
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

companies
ELI LILLY COGILEADLILLY
drugs
Obesity
topics
Psychiatry & CNS9Schizophrenia2ObesityType 2 Diabetes

related stories

  • Jun 2910 clinical trials to watch in the second half of 2026BioPharma Dive
  • 15h agoTrans federal employees sue over revoked health coverageSTAT
  • Jul 23STAT+: Pharmalittle: We’re reading about Lilly obesity drug data, a push for FDA to ban DTC ads, and moreSTAT
  • Jul 9Opinion: Who benefits from classifying obesity as a disease?STAT
  • Jun 9Gilead and Merck’s latest trial success and flopSTAT